79.由trastuzumab的選用，推測歐女士腫瘤的基因體學有何特點？
(A)CD（clusters of differentiation）20 positive
(B)HER2-positive
(C)epidermal growth factor receptor（EGFR）mutation
(D)KRAS wild type

答案：登入後查看
統計： A(21), B(2315), C(91), D(25), E(0) #3133846

詳解 (共 4 筆)

#5900637
Trastuzumab1.是由DNA基因...
(共 158 字，隱藏中）
前往觀看
42
0
#5902399

補充D選項

KRAS wild type是Cetuximab 、Panitumumab的基因體學特點

40
1
#6480689
準藥師您好，這是一題關於腫瘤靶向治療藥...
(共 3136 字，隱藏中）
前往觀看
4
0
#6016338
uptodate:
Trastuzumab, with or without pertuzumab — For those with pathologic complete response following HER2-directed therapy, we continue adjuvant trastuzumab, with or without pertuzumab, to complete a year of HER2-directed therapy.
1
1